Diabetes Mellitus, Type I Clinical Trial
Official title:
The Effect of Exercise on the Development of Hypoglycemia in Children With Type 1 Diabetes; A Study Being Conducted by the Diabetes Research in Children Network
The main purpose of this study is to find out how often low blood sugar (hypoglycemia)
happens during the night after exercise in the late afternoon. The study also will see if
there are any factors that can predict if low blood sugar is going to develop. Blood samples
will also be drawn to measure two hormones—glucagon and epinephrine (adrenaline)—to see how
they are affected by exercise. Glucagon helps to raise the blood sugar when it is low.
Epinephrine causes symptoms that make the person aware that the blood sugar is low. From the
blood sample, other substances in the blood may also be measured to see how they are
affected by exercise.
A second purpose of the study is to find out whether exercise affects the accuracy of a
continuous glucose sensor (CGMS made by Medtronic Minimed).
The study will also look at the accuracy of different home glucose meters.
Many children and adults with type 1 diabetes have a drop in the blood sugar during
exercise. When someone has low blood sugar, the body tries to return the blood sugar to
normal. Some studies show that after exercise, the blood sugar may drop later in the day or
during the night. However, it is not known how often this happens. Also, not enough is known
about how exercise affects blood sugar or the awareness of low blood sugar.
Some studies in adults have shown that exercise may affect the body's natural response to
low blood sugar and exercise in the future.
For this study, each subject will have two in-patient hospital stays 1 to 4 weeks apart,
each lasting about 24 hours: one with no exercise and one with a 75-minute exercise session
in the late afternoon. (The order of the exercise and sedentary days will be determined at
random.)
Prior to each hospital admission, each subject will keep a detailed diary of insulin use and
hypoglycemia for one week.
On each of the two admissions, the insulin regimens and diet will be as similar as possible.
On each of the 2 admissions, the following will occur:
- A CGMS sensor will be inserted and calibrated.
- An intravenous catheter for the collection of blood samples will be inserted.
- Blood sugar measurements will be made with an Ultra, BD Logic, and Freestyle meter
every half hour beginning at 10:00 p.m. through 6:00 a.m.
- Blood samples for glucagon, epinephrine, and glucose will be collected hourly from
10:00 p.m. to 6:00 a.m.
On the exercise day only,
- In the morning, the subject will run on the treadmill for about 5 minutes to determine
the settings needed to achieve a heart rate of 140.
- Exercise will begin at approximately 4:00PM and will consist of 15 minutes on a
treadmill at a heart rate of approximately 140 followed by a 5-minute rest period. This
cycle will be repeated 3 more times for a total of four 15-minute exercise periods with
5-minute rest periods in between (75 minutes total). A heart rate monitor will be worn
throughout the time of exercise to ascertain the effort put forth.
- BG (blood glucose) measurements will be made using the Ultra, BD Logic, and Freestyle
meters (1) prior to starting the exercise, (2) during each of the 3 rest periods, (3)
immediately following the exercise session, and (4) at 15 minute intervals for one hour
following the completion of the exercise. Blood samples will be collected for the
central lab at the times of sampling for glucagon and epinephrine.
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00351234 -
Carnitine Levels and Carnitine Supplementation in Type I Diabetes
|
N/A | |
Recruiting |
NCT00875290 -
The Effectiveness of Continuous Glucose Monitoring in Diabetes Treatment for Infants and Young Children
|
Phase 3 | |
Completed |
NCT00888628 -
Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients
|
Phase 1/Phase 2 | |
Completed |
NCT00147342 -
The Effect of Insulin During Exercise on the Development of Low Blood Sugar in Individuals With Type I Diabetes
|
N/A | |
Completed |
NCT00493935 -
Effect of the Fat Content of the Bedtime Snack on Overnight Hypoglycemia
|
N/A | |
Completed |
NCT00118976 -
Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease
|
N/A | |
Active, not recruiting |
NCT02081326 -
Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes
|
Phase 2 | |
Withdrawn |
NCT00790439 -
Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant
|
Phase 2 | |
Completed |
NCT00789308 -
Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation
|
Phase 2 | |
Completed |
NCT02970357 -
Evaluation of the Impact of a Therapeutic Education Program for Children With Type 1 Diabetes
|
N/A | |
Completed |
NCT02521675 -
Validation of Algorithms for Basal Insulin Rate Reductions in Type 1 Diabetic Patients Practising Physical Activity in Real Life Conditions
|
N/A | |
Completed |
NCT01781975 -
Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus
|
Phase 2 | |
Completed |
NCT00368394 -
Dose-Exposure-Response in Type 1 Diabetes Mellitus
|
Phase 1 | |
Terminated |
NCT04591925 -
SteadiSet™ Pilot Study (SteP Study)
|
N/A | |
Not yet recruiting |
NCT06147583 -
Assessing Detection Algorithms for Insulin Pump Malfunctions in Type 1 Diabetes
|
N/A | |
Active, not recruiting |
NCT00306098 -
Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression
|
Phase 2 | |
Recruiting |
NCT05708820 -
Online Education Programme for People With Type 1 Diabetes and Suboptimal Metabolic Control
|
N/A | |
Completed |
NCT02556554 -
Pilot Prospective CGM Quality Improvement (QI) Project in Pregnancy
|
N/A | |
Completed |
NCT00652288 -
Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs
|
Phase 1 |